Targa Resources Corp. Publishes Updated Investor Presentation

HOUSTON, March 12, 2015 (GLOBE NEWSWIRE) -- Targa Resources Corp. (NYSE: TRGP) ("TRC" or the "Company") has published an updated investor presentation that is available in the Events and Presentations section of the Company's website at www.targaresources.com.

About Targa Resources Corp. and Targa Resources Partners

Targa Resources Corp. is a publicly traded Delaware corporation that owns the general partner interest, all of the outstanding incentive distribution rights and a portion of the outstanding limited partner interests in Targa Resources Partners LP (the "Partnership").

Targa Resources Partners LP is a publicly traded Delaware limited partnership formed in October 2006 by its parent, Targa Resources Corp., to own, operate, acquire and develop a diversified portfolio of complementary midstream energy assets. The Partnership is a leading provider of midstream natural gas and NGL services in the United States, with a growing presence in crude oil gathering and petroleum terminaling. The Partnership is engaged in the business of gathering, compressing, treating, processing and selling natural gas; storing, fractionating, treating, transporting and selling NGLs and NGL products, including services to LPG exporters; gathering, storing and terminaling crude oil; and storing, terminaling and selling refined petroleum products.

The principal executive offices of Targa Resources Corp. and Targa Resources Partners LP are located at 1000 Louisiana, Suite 4300, Houston, TX 77002 and their telephone number is 713-584-1000.

CONTACT: Investor contact:
         (713) 584-1133

         Jennifer Kneale
         Director - Finance

         Matthew Meloy
         Senior Vice President, Chief Financial Officer and Treasurer

You May Also Be Interested In

• Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
• Ascletis Submits Two IND Applications to the U.S. FDA for the Treatment of Obesity: ASC36 Once-Monthly Injection, a Peptide Amylin Receptor Agonist, and ASC36_35 FDC Once-Monthly Injection, a Co-Formu
• Access Advance Welcomes Samsung and Sharp to the VVC Advance Patent Pool